sutent
pfizer limited - sunitinib - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - agentes antineoplásicos - gastrointestinal stromal tumour (gist)sutent is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib mesilate treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sutent is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sutent is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours with disease progression in adults. experience with sutent as first-line treatment is limited (see section 5.
gefitinib teva 250 mg comprimidos recubiertos con pelicula efg
teva b.v. - gefitinib - comprimido recubierto con pelÍcula - 250 mg - gefitinib 250 mg - gefitinib
gefitinib accord 250 mg comprimidos recubiertos con pelicula efg
accord healthcare s.l.u. - gefitinib - comprimido recubierto con pelÍcula - 250 mg - gefitinib 250 mg - gefitinib
gefitinib aristo 250 mg comprimidos recubiertos con pelicula efg
aristo pharma iberia s.l. - gefitinib - comprimido recubierto con pelÍcula - 250 mg - gefitinib 250 mg - gefitinib
gefitinib sandoz 250 mg comprimidos recubiertos con pelcula efg
sandoz farmaceutica s.a. - gefitinib - comprimido recubierto con pelÍcula - 250 mg - gefitinib 250 mg - gefitinib
gefitinib cipla 250 mg comprimidos recubiertos con pelicula efg
cipla europe nv - gefitinib - comprimido recubierto con pelÍcula - 250 mg - gefitinib 250 mg - gefitinib
sunitinib teva 12,5 mg capsulas duras efg
teva b.v. - sunitinib - cÁpsula dura - 12,5 mg - sunitinib 12,5 mg - sunitinib
sunitinib teva 25 mg capsulas duras efg
teva b.v. - sunitinib - cÁpsula dura - 25 mg - sunitinib 25 mg - sunitinib
sunitinib teva 50 mg capsulas duras efg
teva b.v. - sunitinib - cÁpsula dura - 50 mg - sunitinib 50 mg - sunitinib
sunitinib mylan 12,5 mg capsulas duras efg
mylan pharmaceuticals, s.l. - sunitinib - cÁpsula dura - 12,5 mg - sunitinib 12,5 mg - sunitinib